ZYLORIC
GLAXOSMITHKLINE
Advertisement
Active Ingredients
Indications
Uric acid lithiasis, Acute uric acid nephropathy, Myeloproliferative disorders, Neoplastic disease, Idiopathic gout, Enzyme disorders, Reduce uric acid formation in condition where uric acid deposition has already occured, hypoxanthine-guanine phosphoribosyltransferase, including Lesch-Nyhan syndrome, Glucose-6-phosphatase including glycogen storage disease:, phosphoribosylpyrophosphate synthetase, phosphoribosylpyrophosphate amidotransferase, Adenine phosphoribosyltransferase, Recurrent mixed calcium oxalate renal stones in the presence of hyperuricosuria.
Active Ingredients
Indications
Uric acid lithiasis, Acute uric acid nephropathy, Myeloproliferative disorders, Neoplastic disease, Idiopathic gout, Enzyme disorders, Reduce uric acid formation in condition where uric acid deposition has already occured, hypoxanthine-guanine phosphoribosyltransferase, including Lesch-Nyhan syndrome, Glucose-6-phosphatase including glycogen storage disease:, phosphoribosylpyrophosphate synthetase, phosphoribosylpyrophosphate amidotransferase, Adenine phosphoribosyltransferase, Recurrent mixed calcium oxalate renal stones in the presence of hyperuricosuria.